Recent findings have shown that routine eye screening could also be used for early detection of underlying heart disease in ...

Reducing the frequency of eye screening in patients with diabetes from annually to every other year would delay detection of sight-threatening diabetic retinopathy (STDR) and proliferative diabetic ...

Remidio’s diabetic retinopathy AI shows largest real-world evaluation published in Lancet Digital Health: Our Bureau, Bengaluru Friday, January 23, 2026, 13:45 Hrs [IST] Remidio ...

Please provide your email address to receive an email when new articles are posted on . Among diabetes care centers in India, screening for diabetic retinopathy using tele-ophthalmology proved ...

CHENNAI: Mass diabetic retinopathy screening with high predictive accuracy could soon become a reality in high-burden ...

A recent retrospective cross-sectional observational study concluded that the Medios AI system, in conjunction with the Remidio smartphone-based fundus camera, has strong potential to ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

SECAUCUS, N.J., April 4, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a collaboration with IRIS (Intelligent ...

One-third of diabetic adults in the U.S. do not receive annual eye exams. Additionally, lack of pupillary dilation before exams is associated with ungradable, or insufficient exams. In September 2022, ...

AI-based retinal imaging and diagnostics startup AEYE Health announced today it received clearance from the FDA to market its diagnostic screening system for diabetic retinopathy. There are 35 million ...

The Centers for Medicare and Medicaid Services (CMS) will cover an autonomous screening tool and allow it to count toward quality measures. As part of its 2022 Medicare Physician Fee Schedule, CMS set ...